The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $102.30

Today's change+0.50 +0.49%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $102.30

Today's change+0.50 +0.49%
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.

Jazz Pharmaceuticals PLC up (U.S.)$0.50

Jazz Pharmaceuticals PLC closed up Friday by (U.S.)$0.50 or 0.49% to (U.S.)$102.30. Although unchanged over the last five days, shares are down 27.22% for the last year to date. This security has underperformed the S&P 500 by 36.45% during the last year.

Key company metrics

  • Open(U.S.) $101.70
  • Previous close(U.S.) $101.80
  • High(U.S.) $104.99
  • Low(U.S.) $101.37
  • Bid / Ask(U.S.) $86.73 / (U.S.) $102.50
  • YTD % change-27.22%
  • Volume634,634
  • Average volume (10-day)579,414
  • Average volume (1-month)761,352
  • Average volume (3-month)628,901
  • 52-week range(U.S.) $95.80 to (U.S.) $160.00
  • Beta1.29
  • Trailing P/E17.90×
  • P/E 1 year forward10.28×
  • Forward PEG0.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.72
Updated December 9 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.11%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue374381336341
Total other revenue--------
Total revenue374381336341
Gross profit350357313317
Total cost of revenue24242324
Total operating expense239212215234
Selling / general / administrative124123129124
Research & development63394029
Depreciation / amortization26272324
Interest expense (income), net operating--------
Unusual expense (income)10--33
Other operating expenses, total--------
Operating income136169121107
Interest income (expense), net non-operating-18-12-12-12
Gain (loss) on sale of assets--------
Other--------
Income before tax11615710897
Income after tax871117483
Income tax, total29453414
Net income871117483
Total adjustments to net income--------
Net income before extra. items871117483
Minority interest00--0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items871117483
Inc. avail. to common incl. extra. items871117483
Diluted net income871117483
Dilution adjustment--00--
Diluted weighted average shares62626263
Diluted EPS excluding extraordinary itemsvalue per share1.411.801.191.32
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.421.801.161.57